Mikkel Hasse Pedersen (Mikkel H Pedersen)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 11

Top Topics

Allergic Rhinitis

Obstructive Sleep Apnea

Top Venues

Current medical research and opinion

Journal of medical economics

Patient preference and adherence

Acta oncologica (Stockholm, Sweden)

This page only lists publications with an associated author ORCID identifier.

Publications

Mikkel Hasse Pedersen, Anne Danø, Ebbe Englev, Lisbeth Kattenhøj, Emma Munk
Economic benefits of remimazolam compared to midazolam and propofol for procedural sedation in colonoscopies and bronchoscopies. Current medical research and opinion (2023)
Jan H Rudolfsen, Mads D Hjortsø, Mikkel Hasse Pedersen, Trine Pilgaard, Mette Pøhl
Impact of new cancer medicine - real-world evidence from Danish register study of lung cancer patients. Acta oncologica (Stockholm, Sweden) (2023)
Maria Spanggaard, Mette Bøgelund, Carsten Dirksen, Nils Bruun Jørgensen, Steen Madsbad, Ulrik Haagen Panton, Mikkel Hasse Pedersen, Signe Baattrup Reitzel, Pierre Johansen
The substantial costs to society associated with obesity - a Danish register-based study based on 2002-2018 data. Expert review of pharmacoeconomics & outcomes research 22 (5) (2022)
Mikkel Hasse Pedersen, Anne Danø, Carl Gibbons, Rasmus Jensen
Administration and patient-incurred costs associated with opioid agonist treatment in Norway. Current medical research and opinion 38 (11) (2022)
Mette Bøgelund, Ana Rosado Ingelmo, Jose María Ausín Ruiz, Adolfo Galán Vivó, Henrik Brandi, Mikkel Hasse Pedersen, Anne Sofie Ledgaard Loftager, Mark Aagren
Preference for sublingual immunotherapy with tablets in a Spanish population with allergic rhinitis. Clinical and translational allergy 12 (2) (2022)
Mikkel Hasse Pedersen, Mette Bøgelund, Carsten Dirksen, Pierre Johansen, Nils B Jørgensen, Sten Madsbad, Ulrik H Pantin
The prevalence of comorbidities in Danish patients with obesity - A Danish register-based study based on data from 2002 to 2018. Clinical obesity 12 (5) (2022)
Anders Muusfeldt Birck, Liv Nordin Christensen, Mikkel Hasse Pedersen, Jens Olsen, Kelly D Johnson, Goran Bencina, Thomas Holtkøtter Clausen, Carsten Schade Larsen
Health economic evaluation of introducing a PPSV23-based vaccination programme to adults aged 65 and above, and an extension to the 60-64 age group in Denmark. Expert review of vaccines 20 (10) (2021)
Mike Tankersley, Tonya Winders, Mark Aagren, Henrik Brandi, Mikkel Hasse Pedersen, Anne Sofie Ledgaard Loftager, Mette Bøgelund
Subcutaneous immunotherapy takes more than the time in the clinic. Current medical research and opinion 37 (11) (2021)
Alexander Egeberg, Anne Danø, Mikkel Hasse Pedersen, Anne Sohrt, Emma Borg, Jaime Notario
Modeling the optimal sequence of biologic therapies in plaque psoriasis in Spain. Journal of medical economics 24 (1) (2021)
Mike Tankersley, Tonya A Winders, Mark Aagren, Henrik Brandi, Mikkel Hasse Pedersen, Anne Sofie Ledgaard Loftager, Mette Bøgelund
Preference for Immunotherapy with Tablets by People with Allergic Rhinitis. Patient preference and adherence 15 (2021)
Trine Pilgaard, Mikkel Hasse Pedersen, Steen Hvitfeldt Poulsen
Diagnostic and lifetime hospital costs of patients suffering from wild-type transthyretin amyloid cardiomyopathy in Denmark. Journal of medical economics 23 (10) (2020)